PATENT CLAIM ANALYSIS

Application Number: 15769596
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["424", "450000"]

Abstract:
The present invention relates to liposomal compositions, comprising liposomes containing tetraether lipids (TELs), and further comprising the lipopeptide Myr-HBVpreS/2-48 (Myrcludex B) as part of said liposomes, as well as uses thereof for the prevention or treatment of hepatic disorders or diseases, and/or for the oral hepatic delivery of therapeutic and/or diagnostic agents.

Claim (Index 2):
The liposomal composition according to  claim 1 , wherein said TELs are derived from  Sulfolobus  sp.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 91.0
- Lexical Diversity: 1.38636
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15769630', '11131436', '14492060', '15891170', '15503010']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7452769580514981
- 35 USC 102 Novelty (BERT): 0.5573502910399296
- Combined Prediction Score: 0.7264842913503412
- Mean Citation Score: 278.81567600000005
- Max Citation Score: 415.0821
- Similarity Product: 412.0127042498232

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test